Dr Moorman's highlights on mixed phenotype acute leukemia (MPAL) from ASH 2016
Managing relapse in AML: the role of MRD
Preliminary results of ibruntinib in combination with FCR chemotherapy for CLL
Clinical implications of persisting preleukemic clones in remission in acute myeloid leukemia (AML)
Treatment for older AML patients - when is an allogeneic transplant suitable?